ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 966 filers reported holding ASTRAZENECA PLC in Q1 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $928,604 | +19.5% | 13,712 | +26.3% | 0.15% | +25.9% |
| Q2 2023 | $776,941 | -2.5% | 10,856 | -5.5% | 0.12% | -10.1% |
| Q1 2023 | $797,042 | -3.2% | 11,484 | -5.4% | 0.13% | -11.6% |
| Q4 2022 | $823,447 | -0.4% | 12,145 | -19.5% | 0.15% | -10.4% |
| Q3 2022 | $827,000 | -19.5% | 15,080 | -3.1% | 0.16% | -17.3% |
| Q2 2022 | $1,027,000 | -21.0% | 15,557 | -20.6% | 0.20% | -25.9% |
| Q1 2022 | $1,300,000 | +8.4% | 19,591 | -4.8% | 0.27% | +10.4% |
| Q4 2021 | $1,199,000 | -2.9% | 20,586 | +0.1% | 0.24% | -13.0% |
| Q3 2021 | $1,235,000 | +17.6% | 20,566 | +17.4% | 0.28% | +12.1% |
| Q2 2021 | $1,050,000 | +38.3% | 17,524 | +14.8% | 0.25% | +16.0% |
| Q1 2021 | $759,000 | +7.2% | 15,262 | +7.7% | 0.21% | +1.9% |
| Q4 2020 | $708,000 | -4.7% | 14,167 | +4.5% | 0.21% | -21.7% |
| Q3 2020 | $743,000 | +4.6% | 13,562 | +1.1% | 0.27% | -4.6% |
| Q2 2020 | $710,000 | +86.4% | 13,418 | +57.3% | 0.28% | +36.6% |
| Q1 2020 | $381,000 | – | 8,528 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |